The Clorox Company CLX
93.86 USD +3.95 (+4.40%)
Nov 3, 2026, 3:53 PM EST
91.59 Day range 95.24
80.41 52-week range 127.16
- YTD
- -6.92%
- 1 year
- -14.00%
Analyst view
Consensus: hold
Hold
Price target (mean) 96.35 +2.7% upside
Now 93.86
- Target (low)
- 74.00
- Target (mean)
- 96.35
- Target (high)
- 154.00
Ratings (0m) 19 1 buy · 14 hold · 4 sell
- Strong buy0
- Buy1
- Hold14
- Sell2
- Strong sell2
Recommendation trend
- This month 19
- 1 month ago 19
- 2 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.07 | 0.81 – 1.20 | 0.85 | +26.1% | 1.88B | +31.3% | 15 |
| Next quarter | 1.34 | 1.22 – 1.47 | 1.39 | -3.9% | 1.89B | +13.0% | 15 |
| Current year | 5.70 | 5.30 – 5.85 | 5.53 | +3.1% | 7.63B | +13.5% | 19 |
| Next year | 6.13 | 5.64 – 6.56 | 5.70 | +7.6% | 7.81B | +2.3% | 18 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Evercore ISI Group | Upgrade | Underperform | In-Line |
| Oct 19, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Oct 16, 2026 | Barclays | Maintained | Underweight | Underweight |
| Oct 15, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 14, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Oct 5, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Sep 11, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Sep 11, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 4, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 4, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Aug 4, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 4, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 4, 2026 | Evercore ISI Group | Maintained | Underperform | Underperform |
| Jul 28, 2026 | Jefferies | Downgrade | Buy | Hold |
| Jul 23, 2026 | Evercore ISI Group | Maintained | Underperform | Underperform |
| Jul 21, 2026 | Barclays | Maintained | Underweight | Underweight |
| Jul 20, 2026 | BNP Paribas | Maintained | Neutral | Neutral |
| Jul 16, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Jul 16, 2026 | UBS | Maintained | Neutral | Neutral |
| May 18, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 4, 2026 | Barclays | Maintained | Underweight | Underweight |
| May 1, 2026 | UBS | Maintained | Neutral | Neutral |
| May 1, 2026 | Citigroup | Maintained | Neutral | Neutral |
| May 1, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| May 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 1, 2026 | Evercore ISI Group | Maintained | Underperform | Underperform |
| Apr 23, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 21, 2026 | Jefferies | Maintained | Buy | Buy |
| Apr 17, 2026 | JP Morgan | Downgrade | Neutral | Underweight |
